Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind

Capecitabine is an orally administered fluoropyrimidine carbamate antineoplastic agent, widely used to treat different tumor types. Eye toxicity is not well established with this type of drug. Here, we report the case of a 57-year-old man with a low rectal cancer whose vision decreased 3 weeks after starting a daily treatment of capecitabine and radiotherapy. After eliminating all other diagnoses, toxicity of antineoplastic agents remains the most likely hypothesis, making it the first case of vision loss induced by this capecitabine.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind ; volume:16 ; number:1 ; year:2023 ; pages:480-483 ; extent:4
Case reports in oncology ; 16, Heft 1 (2023), 480-483 (gesamt 4)

Creator
Matte, Paul
Ducreux, Michel

DOI
10.1159/000530402
URN
urn:nbn:de:101:1-2023122723452416264247
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Matte, Paul
  • Ducreux, Michel

Other Objects (12)